On the other hand, these drugs may reduce significantly insulin levels and the insulin/glucose index, as well as improve insulin resistance [58, 87] and also a dramatic reduction of resistin, an adipokine that showed strong correlation with C-reactive protein, was observed following infliximab infusion in RA patients undergoing this therapy because of severe disease [88]. Here, RETN is linked to rheumatoid arthritis.